Substance use-related problems in mild intellectual disability: A Swedish nationwide population-based cohort study with sibling comparison

JCPP advances Pub Date : 2024-02-18 DOI:10.1002/jcv2.12225
Andreas Påhlsson-Notini, Shengxin Liu, Magnus Tideman, Antti Latvala, Eva Serlachius, Henrik Larsson, Tatja Hirvikoski, Mark J. Taylor, Ralf Kuja-Halkola, Paul Lichtenstein, Agnieszka Butwicka
{"title":"Substance use-related problems in mild intellectual disability: A Swedish nationwide population-based cohort study with sibling comparison","authors":"Andreas Påhlsson-Notini,&nbsp;Shengxin Liu,&nbsp;Magnus Tideman,&nbsp;Antti Latvala,&nbsp;Eva Serlachius,&nbsp;Henrik Larsson,&nbsp;Tatja Hirvikoski,&nbsp;Mark J. Taylor,&nbsp;Ralf Kuja-Halkola,&nbsp;Paul Lichtenstein,&nbsp;Agnieszka Butwicka","doi":"10.1002/jcv2.12225","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Evidence for substance use-related problems in individuals with mild intellectual disability is sparse and mainly limited to selected psychiatric populations. We evaluated the risk of substance use-related problems in individuals with mild intellectual disability compared to the general population. Additionally, we have performed secondary sibling comparison analyses to account for familial confounding.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We conducted a population-based cohort study of individuals born in Sweden between 1973 and 2003. A total of 18,307 individuals with mild intellectual disability were compared to 915,350 reference individuals from the general population and 18,996 full siblings of individuals with mild intellectual disability. Information on mild intellectual disability and substance use-related problems was obtained from several Swedish national and regional school and healthcare registers. Substance use-related problems were measured via corresponding diagnostic and legal codes and included alcohol use disorder, drug use disorder, alcohol-related somatic disease, conviction for a substance-related crime, and substance-related death.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Individuals with mild intellectual disability had a higher risk of any substance use-related problem compared to the general population (HR, 1.81; 95% CI, 1.72–1.91), both in males (HR, 1.76; 95% CI, 1.65–1.89) and females (HR, 1.89; 95% CI, 1.74–2.05). The risks of substance use-related problems were particularly elevated among individuals with mild intellectual disability and psychiatric comorbidities (HR, 2.21–8.24). The associations were attenuated in the sibling comparison models.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Individuals with mild intellectual disability, especially those with psychiatric comorbidity, are at an elevated risk of substance use-related problems. Familial factors shared by full siblings contribute considerably to the association between mild intellectual disability and substance use-related problems.</p>\n </section>\n </div>","PeriodicalId":73542,"journal":{"name":"JCPP advances","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcv2.12225","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCPP advances","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jcv2.12225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Evidence for substance use-related problems in individuals with mild intellectual disability is sparse and mainly limited to selected psychiatric populations. We evaluated the risk of substance use-related problems in individuals with mild intellectual disability compared to the general population. Additionally, we have performed secondary sibling comparison analyses to account for familial confounding.

Methods

We conducted a population-based cohort study of individuals born in Sweden between 1973 and 2003. A total of 18,307 individuals with mild intellectual disability were compared to 915,350 reference individuals from the general population and 18,996 full siblings of individuals with mild intellectual disability. Information on mild intellectual disability and substance use-related problems was obtained from several Swedish national and regional school and healthcare registers. Substance use-related problems were measured via corresponding diagnostic and legal codes and included alcohol use disorder, drug use disorder, alcohol-related somatic disease, conviction for a substance-related crime, and substance-related death.

Results

Individuals with mild intellectual disability had a higher risk of any substance use-related problem compared to the general population (HR, 1.81; 95% CI, 1.72–1.91), both in males (HR, 1.76; 95% CI, 1.65–1.89) and females (HR, 1.89; 95% CI, 1.74–2.05). The risks of substance use-related problems were particularly elevated among individuals with mild intellectual disability and psychiatric comorbidities (HR, 2.21–8.24). The associations were attenuated in the sibling comparison models.

Conclusions

Individuals with mild intellectual disability, especially those with psychiatric comorbidity, are at an elevated risk of substance use-related problems. Familial factors shared by full siblings contribute considerably to the association between mild intellectual disability and substance use-related problems.

Abstract Image

轻度智障者的药物使用相关问题:一项基于同胞比较的瑞典全国人群队列研究
有关轻度智障者药物使用相关问题的证据很少,而且主要局限于特定的精神病人群。与普通人群相比,我们评估了轻度智障者出现药物使用相关问题的风险。此外,我们还进行了次级同胞比较分析,以考虑家族混杂因素。我们对 1973 年至 2003 年间在瑞典出生的人进行了一项基于人群的队列研究。共有 18,307 名轻度智障者与 915,350 名普通人群中的参照个体以及 18,996 名轻度智障者的同胞兄弟姐妹进行了比较。有关轻度智障和药物使用相关问题的信息来自瑞典多个国家和地区的学校及医疗登记册。与药物使用相关的问题通过相应的诊断和法律代码来衡量,包括酒精使用障碍、药物使用障碍、与酒精相关的躯体疾病、与药物相关的犯罪定罪以及与药物相关的死亡。与普通人群相比,轻度智障者出现任何药物使用相关问题的风险更高(HR,1.81;95% CI,1.72-1.91),男性(HR,1.76;95% CI,1.65-1.89)和女性(HR,1.89;95% CI,1.74-2.05)均是如此。有轻度智力障碍和精神病合并症的人出现药物使用相关问题的风险尤其高(HR,2.21-8.24)。在同胞比较模型中,相关性有所减弱。轻度智力障碍者,尤其是合并精神疾病者,出现药物使用相关问题的风险较高。全兄弟姐妹共有的家族因素在很大程度上导致了轻度智力障碍与药物使用相关问题之间的关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信